NOCIL Q1 Results FY27: PAT at Rs 28 Cr for June 2026 Quarter
- August 3, 2026
- Posted by: Kunal Singla
- Category: News
NOCIL Q1 FY27: PAT Rs 28 Cr (+65.00% YoY) | Revenue Rs 403 Cr (+20.00% YoY) | EBITDA margin 11.2%. Reported 2:40 PM IST, 3 August 2026.
The NOCIL Q1 results FY27 show revenue of Rs 403 Cr for the quarter ended 30 June 2026, +20.00% year on year from Rs 336 Cr in Q1 FY26, as NOCIL reported its June quarter numbers at 2:40 PM IST on 3 August 2026. NOCIL posted net profit of Rs 28 Cr for the quarter, against Rs 17 Cr in Q1 FY26, a change of +65.00%.
The rubber chemicals industry is tightly linked to tyre and automotive output. Domestic tyre production has been healthy on the back of strong OEM and replacement demand, supporting volumes for antidegradant and accelerator makers. Margin recovery depends on NOCIL-specific capacity utilisation and raw material (aniline, diphenylamine) prices. Against that backdrop, the NOCIL Q1 results FY27 give investors the first hard data point for FY27. This article breaks down what happened at the revenue, operating, and net profit line, what the numbers mean for the full year, and what questions investors should be asking before making any portfolio decision.
Click Here – Get Free Investment Predictions
NOCIL Q1 Results FY27 Financial Highlights
All figures below are as reported by NOCIL and sourced from the Q1 FY27 results announcement. Revenue figures are in Rs Crore (3 August 2026).
| Metric | Q1 FY27 (Jun 2026) | Q1 FY26 (Jun 2025) | YoY Change |
|---|---|---|---|
| Revenue | Rs 403 Cr | Rs 336 Cr | +20.00% |
| EBITDA | Rs 45 Cr | Rs 30 Cr | +50.00% |
| EBITDA Margin | 11.2% | 8.9% | +2.3 pts |
| PAT | Rs 28 Cr | Rs 17 Cr | +65.00% |
NOCIL Q1 FY27 Performance Analysis
Revenue came in at Rs 403 Cr for the June 2026 quarter, up +20.00% from Rs 336 Cr in Q1 FY26. The pace is moderate but consistent, the kind of compounding that, if sustained, translates into meaningful earnings growth over a full financial year.
The operating performance was the bright spot. EBITDA came in at Rs 45 Cr at 11.2% of revenue, up +50.00% year on year from Rs 30 Cr. Margin expanded by 2.3 percentage points year on year to 11.2%, a healthy sign of operating efficiency gains. The positive operating jaws, EBITDA growing faster than revenue, is precisely what investors in this sector look for as proof of a durable model.
The bottom line was the cleanest positive in the release. NOCIL posted net profit (PAT) of Rs 28 Cr for the quarter, up +65.00% from Rs 17 Cr in Q1 FY26. The combination of revenue growth and margin resilience is translating into a meaningfully higher earnings figure, the outcome investors were hoping to see.
Check the Univest Screener for Live Data
NOCIL Q1 FY27: Key Business Factors
1. Revenue: What Drove the Quarter
NOCIL has been investing in expansion, whether in hospital beds, product launches, branch network, or distribution reach, and this quarter’s revenue figure of Rs 403 Cr is the quantitative outcome of that investment. The +20.00% year on year growth from Rs 336 Cr in Q1 FY26 needs to be read alongside capacity utilisation and realisation trends to fully understand its quality. High revenue growth driven by volume is typically more durable than pricing-led growth, and vice versa. Until management provides the breakdown, the aggregate figure is the best available data. Investors should check the investor presentation, usually released alongside the results or in a 24-hour window, for this split.
2. EBITDA and Margins: The Operating Health Check
EBITDA margin expanded to 11.2% from 8.9% in Q1 FY26, a gain of 2.3 percentage points. This expansion is meaningful because it tells investors that NOCIL is growing without sacrificing the quality of its earnings. Margin improvement at this level suggests some combination of operating efficiency gains (fixed costs being spread over a larger revenue base), procurement efficiency, or favourable product mix. Sustaining this margin in the face of potential input cost inflation will be the key operating challenge for management in the second half of FY27.
3. PAT: What the Bottom Line Tells You
NOCIL reported net profit of Rs 28 Cr for the quarter against Rs 17 Cr a year earlier. The net profit is the number that ultimately flows through to earnings per share (EPS) and determines the P/E multiple at which the stock trades. A +65.00% year on year improvement in this line is the most positive element of the quarterly results from a valuation standpoint. Analysts will now update their full-year FY27 earnings estimates based on this Q1 run rate and any guidance that management provides alongside the results.
NOCIL Q1 FY27 Results vs Expectations
Analyst estimates for the NOCIL Q1 results FY27 varied ahead of the announcement. The actual revenue of Rs 403 Cr and net profit of Rs 28 Cr now set the benchmark against which FY27 consensus estimates will be revised. When a company beats on revenue and earnings simultaneously, the first trading session typically sees a positive price reaction as short sellers cover and institutional buyers step in. A miss on both is the reverse. A mixed print, beating on one line and missing on another, is harder to read and usually means the stock stays range-bound until the conference call provides clarity. Investors can track how NOCIL is trading on the Univest Screener alongside analyst verdict updates after this result.
Dividend Update
Specific dividend information was not confirmed as part of this results snapshot. Most companies declare their dividend at the annual board meeting rather than the Q1 result. Investors tracking NOCIL for its dividend yield should check the official NSE or BSE exchange filing, the company’s investor relations page, or the Univest Screener for the latest record date and payout details.
NOCIL Outlook After the Q1 FY27 Results
For NOCIL specifically, the Q1 FY27 trends point to growth in revenue and improvement in the bottom line. Whether FY27 ends up as a year of acceleration, consolidation, or pressure depends largely on two variables: whether the growth in revenue sustains through Q2-Q4, and whether margin trends improve, stabilise, or deteriorate relative to this quarter’s print. Management guidance, either in a formal earnings call or through an investor presentation, will be the single most important datapoint for updating FY27 forecasts.
The Q1 FY27 print gives investors a base to work from, but one quarter is rarely enough to conclude a trend. The key follow-up question for NOCIL is whether the Q1 performance was driven by seasonal tailwinds or something more durable. Q2 FY27 results, due around October 2026, will be the first test of that. Investors should also watch for any corporate actions, debt announcements, or management changes in the interim.
Is NOCIL a Good Buy After the Q1 FY27 Results?
The question investors most want answered after any quarterly result is whether it changes the investment thesis. For NOCIL, the NOCIL Q1 results FY27 show revenue of Rs 403 Cr, EBITDA of Rs 45 Cr, and net profit of Rs 28 Cr. Whether these numbers are ‘good’ depends on the price the stock is trading at, the FY27 full-year earnings estimate, and whether this Q1 run-rate is sustainable for the remaining three quarters. Investors should check the P/E, P/B, and EV/EBITDA multiples on the Univest Screener against sector peers before deciding. This article is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment advisor (Univest is SEBI RA INH000013776) before making any investment decision.
NOCIL Share Price After the Q1 Results
Live price data for NOCIL was not part of the results snapshot, but the stock typically reacts to Q1 results in the trading session following the announcement. Investors should check the live quote, the 52 week high and low, and technical support and resistance levels on the Univest Screener to contextualise the post-result price move before taking any action. A short-term price move immediately after results is often driven by event-driven traders rather than fundamental investors, and can reverse within the first few sessions.
Download the Univest iOS App or Univest Android App to track NOCIL live share price and upcoming quarterly results.
Key Risks Investors Should Track
Before acting on the NOCIL Q1 results FY27, investors should weigh these risks carefully.
1. Sector and Margin Risk
NOCIL operates in the broader market, which is exposed to input cost movements, demand cyclicality and competitive intensity. A reversal in the trends visible in the Q1 FY27 numbers, particularly on the margin front, could put the full-year FY27 earnings estimate at risk and weigh on the stock.
2. Single-Quarter Noise vs Trend
Quarterly results can be distorted by working capital cycles, timing of receivables, or one-off costs and reversals. The Q1 FY27 print should be read alongside Q2 trends before drawing conclusions about the underlying trajectory of the business.
3. Macro and External Risk
Broader macro factors, RBI rate decisions, INR/USD movements, global commodity prices, and rural versus urban demand splits, can shift the business environment in the broader market faster than company-level actions can compensate for.
Conclusion
The NOCIL Q1 results FY27 show revenue of Rs 403 Cr (+20.00% year on year) and net profit of Rs 28 Cr (versus Rs 17 Cr in Q1 FY26). EBITDA came in at Rs 45 Cr with a 11.2% margin. Revenue growth and a stronger bottom line were the two key themes of the quarter. Investors tracking NOCIL should use this result as the Q1 FY27 baseline and watch Q2 FY27 results, due around October 2026, as the first real test of whether these trends are durable. Always consult a SEBI-registered advisor before acting on any quarterly result.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on NOCIL Q1 Results FY27
What were NOCIL’s Q1 FY27 results?
Ans. NOCIL reported revenue of Rs 403 Cr for Q1 FY27 (quarter ended 30 June 2026), up +20.00% year on year from Rs 336 Cr in Q1 FY26. PAT came in at Rs 28 Cr, compared with Rs 17 Cr a year ago, a change of +65.00%.
What is the PAT in NOCIL Q1 results FY27?
Ans. NOCIL reported net profit of Rs 28 Cr for Q1 FY27, versus Rs 17 Cr in Q1 FY26. The change was +65.00%.
What was NOCIL’s revenue in Q1 FY27?
Ans. NOCIL reported revenue of Rs 403 Cr for the June 2026 quarter, a change of +20.00% from Rs 336 Cr in Q1 FY26.
What was the EBITDA in NOCIL Q1 FY27 results?
Ans. EBITDA for the quarter was Rs 45 Cr, up +50.00% from Rs 30 Cr in Q1 FY26. EBITDA margin was 11.2%.
When did NOCIL announce Q1 FY27 results?
Ans. NOCIL announced its Q1 FY27 results at 2:40 PM IST on 3 August 2026, for the quarter ended 30 June 2026. Investors should confirm the exact board meeting date and the results filing date from the official NSE or BSE announcement.
What is the outlook for NOCIL after the Q1 FY27 results?
Ans. Following the Q1 FY27 results, analysts will update FY27 estimates for NOCIL based on the quarterly run rate. Key things to watch: whether the growth in revenue continues into Q2 FY27, the trajectory of margins, and management guidance in the earnings call.
Is NOCIL a good investment after Q1 FY27 results?
Ans. Investment decisions should be based on the stock’s current valuation relative to its earnings trajectory, not on a single quarterly result in isolation. The Q1 FY27 numbers (revenue Rs 403 Cr, net profit Rs 28 Cr) provide the Q1 baseline. Check the P/E and peer comparison on the Univest Screener and consult a SEBI-registered advisor before investing.